BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2123009)

  • 21. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    Patel A; Craig RH; Daluge SM; Linden J
    Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors.
    Ströher M; Nanoff C; Schütz W
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):87-92. PubMed ID: 2797219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent affinity of 1,3-dipropyl-8-cyclopentylxanthine for adenosine A1 and A2 receptors in isolated tissues from guinea-pigs.
    Collis MG; Stoggall SM; Martin FM
    Br J Pharmacol; 1989 Aug; 97(4):1274-8. PubMed ID: 2790383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonists and antagonists recognize different but overlapping populations of A1 adenosine receptors: modulation of receptor number by MgCl2, solubilization, and guanine nucleotides.
    Olah M; Stiles GL
    J Neurochem; 1990 Oct; 55(4):1432-8. PubMed ID: 2398364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
    Nanoff C; Mitterauer T; Roka F; Hohenegger M; Freissmuth M
    Mol Pharmacol; 1995 Nov; 48(5):806-17. PubMed ID: 7476910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells.
    Gerwins P; Fredholm BB
    Mol Pharmacol; 1991 Aug; 40(2):149-55. PubMed ID: 1652051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.
    Leung E; Green RD
    Mol Pharmacol; 1989 Sep; 36(3):412-9. PubMed ID: 2506430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go.
    Munshi R; Pang IH; Sternweis PC; Linden J
    J Biol Chem; 1991 Nov; 266(33):22285-9. PubMed ID: 1939250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coupling of adenosine receptors to adenylate cyclase in postischemic rat brain.
    Domanska-Janik K; Pyłowa S; Zalewska T
    Cell Signal; 1993 May; 5(3):337-43. PubMed ID: 8394099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.
    Brown HA; Lazarowski ER; Boucher RC; Harden TK
    Mol Pharmacol; 1991 Nov; 40(5):648-55. PubMed ID: 1944236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.
    Lohse MJ; Lenschow V; Schwabe U
    Mol Pharmacol; 1984 Jul; 26(1):1-9. PubMed ID: 6087114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
    Leid M; Schimerlik MI; Murray TF
    Mol Pharmacol; 1989 Apr; 35(4):450-7. PubMed ID: 2495433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between adenosine receptors and adenylate cyclase in the smooth muscle of guinea pig myometrium.
    Smith MA; Silverstein JL; Westfall DP; Buxton IL
    Cell Signal; 1989; 1(4):357-65. PubMed ID: 2642029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
    Lorenzen A; Fuss M; Vogt H; Schwabe U
    Mol Pharmacol; 1993 Jul; 44(1):115-23. PubMed ID: 8341267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of agonist-antagonist interactions at A1 adenosine receptors.
    Leung E; Jacobson KA; Green RD
    Mol Pharmacol; 1990 Jul; 38(1):72-83. PubMed ID: 2115114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB; Horowitz B; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.
    Larrouy D; Galitzky J; Lafontan M
    Eur J Pharmacol; 1991 Feb; 206(2):139-47. PubMed ID: 2065717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.
    Collis MG; Jacobson KA; Tomkins DM
    Br J Pharmacol; 1987 Sep; 92(1):69-75. PubMed ID: 3664093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A1 adenosine receptor stimulation of IP1 degradation in myometrial smooth muscle.
    Schiemann WP; Buxton IL
    Proc West Pharmacol Soc; 1991; 34():261-8. PubMed ID: 1664959
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between guanine nucleotide effect and reversible binding property of endothelin analogs.
    Nambi P; Pullen M; Aiyar N
    Neuropeptides; 1996 Feb; 30(1):109-14. PubMed ID: 8868308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.